Difference between revisions of "Part:BBa K187021:Experience"

(Applications of BBa_K187021)
(Applications of BBa_K187021)
 
Line 5: Line 5:
 
===Applications of BBa_K187021===
 
===Applications of BBa_K187021===
  
This part was used with the Biobytes assembly method to construct a plasmid consisting of this promoter, a kanamycin resistance gene (BBa_K187021) and an origin of replication (using primers entered as BBa_187424 and BBa_K187425).
+
This part was used with the Biobytes assembly method to construct a plasmid consisting of the 75% promoter (BBa_K187007), this kanamycin resistance gene (BBa_K187021) and an origin of replication (using primers entered as BBa_187424 and BBa_K187425).
  
 
Once the linear chain was complete, an annealed terminator was added and the contruct was cleaved from the bead using USER. The sample was heated and cooled slowly to allow proper annealing of the ends before transformation. The anneal construct was transformed into E. coli and plated on Kanamycin containing LB plates. After growing overnight, we counted 105 colonies. Ten colonies were screened by digestion with I-SceI, which was expected to linearize the plasmid. The expected length of the linearized construct was 1595bp (Figure 2).
 
Once the linear chain was complete, an annealed terminator was added and the contruct was cleaved from the bead using USER. The sample was heated and cooled slowly to allow proper annealing of the ends before transformation. The anneal construct was transformed into E. coli and plated on Kanamycin containing LB plates. After growing overnight, we counted 105 colonies. Ten colonies were screened by digestion with I-SceI, which was expected to linearize the plasmid. The expected length of the linearized construct was 1595bp (Figure 2).

Latest revision as of 00:40, 22 October 2009

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K187021

This part was used with the Biobytes assembly method to construct a plasmid consisting of the 75% promoter (BBa_K187007), this kanamycin resistance gene (BBa_K187021) and an origin of replication (using primers entered as BBa_187424 and BBa_K187425).

Once the linear chain was complete, an annealed terminator was added and the contruct was cleaved from the bead using USER. The sample was heated and cooled slowly to allow proper annealing of the ends before transformation. The anneal construct was transformed into E. coli and plated on Kanamycin containing LB plates. After growing overnight, we counted 105 colonies. Ten colonies were screened by digestion with I-SceI, which was expected to linearize the plasmid. The expected length of the linearized construct was 1595bp (Figure 2).

From this digestion, we observed that 8/10 of the screened colonies are the expected length. This was confirmed by sequencing.

User Reviews

UNIQea6970ed2a7a3004-partinfo-00000000-QINU UNIQea6970ed2a7a3004-partinfo-00000001-QINU